Antiproliferative Agents Market: Current Analysis and Forecast (2022-2028)
Emphasis on Drug type (Immunosuppressant’s, alkylating agents, nitrosourea and others); Dosage Form (Tablet, capsules, injections and others) Route of administration (Intravenous, oral and other) Indication (autoimmune, cancer, organ transplant, non-inflammatory diseases and others) and End-Users (Hospitals and retail pharmacy) and Region/Country
The Antiproliferative Agents Market is expected to grow at a strong CAGR of ~ 8.5% during the forecast period (2022-2028). Antiproliferative is a process of tending to suppress cell growth, especially the growth of malignant cells into the surrounding tissue. The rising demand for organ transplants globally. Additionally, government initiatives and an increase in the geriatric population are driving the market. Furthermore, the rise in the prevalence of chronic diseases coupled with an increase in the prevalence of autoimmune diseases is driving the market for antiproliferative agents. For instance, as stated by the National Stem Cells Foundation, in 2023, nearly 4% of the world is affected by 1 or 80 different autoimmune diseases the most common autoimmune disease includes multiple sclerosis, rheumatoid arthritis, lupus, Crohn’s disease, psoriasis and scleroderma.
Some of the major players operating in the market include Accord Healthcare, F. Hoffmann-La Roche Ltd, Novartis Pharmaceuticals, Glenmark Pharmaceuticals U.S. Inc., GlaxoSmithKline, Johnson & Johnson Services, Inc.,Cedilla Pharmaceuticals., AstraZeneca LP, Lupin., Cipla Inc.
Insights Presented in the Report
“Amongst drug type, the Immunosuppressant segment held a dominating share of the market in 2021”
By drug type, the market is segmented into immunosuppressants, alkylating agents, nitrosourea and others. Amongst these, the immunosuppressant segment dominated the market in 2021. This is because of the growing prevalence of autoimmune diseases and increasing procedures of organ transplantation globally. For instance, according to the report from Organ Procurement and Transplantation Network (OPTN), in 2021 41,357 organ transplantation surgeries were performed in the U.S. There was an increase of 5.9% from 2020.
“Amongst dosage forms, the injections segment held the majority share of the market in 2021”
By dosage form, the market is segmented into tablets, capsules, injections, and others. Among these, the injectable segment will capture the majority share of the antiproliferative agents market in 2021. The majority share of injections can be attributed to the advantages it offers such as It allows maximum bioavailability at rapid transportation of the pharmaceutical drug as it bypasses the first pass metabolism. Thus, it is considered to be one of the most effective routes of administration. Furthermore, during a surgical procedure, such as organ transplantation, where instant action is desired and the patient is in a comatose state, in such conditions injection is the preferred dosage form by the doctors.
“Amongst routes of administration, the Oral route segment held the majority share of the market in 2021”
By route of administration, the market is segmented into oral, Intravenous and others. Amongst this, the oral segment will capture the majority of the share of the antiproliferative agent market in 2021. The majority share of the oral route can be attributed towards the patient preference as this route of drug administration is non-invasive, patient compliance, and is the convenient route of drug administration. Furthermore, in chronic disease cases such as hormonal disorders, and autoimmune diseases where surgeries are rarely performed, in such situations, the solid oral dosage form is the preferred dosage form for the treatment of disease by doctors. Moreover, after the post-operative surgical procedure where maintenance therapy is required in such cases drug administered oral route is the preferred drug of choice by the doctors.
“Amongst indication, the cancer segment held the majority share of the market in 2021”
Based on indication, the market is segmented as autoimmune, cancer, organ transplant, non-inflammatory disease and others. Amongst these, the cancer segment would hold the dominating share during the forecasting period. For instance, according to the World Health Organization (W.H.O.) International Agency for Research Centre the prevalence of cancer cases would increase to 24.6M in 2030 from 19.3M in 2020. Additionally, as per the above-mentioned source, increasing obesity due to a sedentary lifestyle, consumption of processed food & sugary beverages, and increased alcohol consumption are the contributing factors to the rise in cancer prevalence globally.
“Amongst end-user, the hospital segment held the majority share of the market in 2021”
By end-users, the market is segmented into hospitals, retail pharmacy and others. Amongst these, the hospital pharmacy segment holds the majority of the share during the forecasting period. This is due to patients’ preference for purchasing medicine from hospitals over outside retail pharmacy. Furthermore, hospital pharmacy source is reliable and safe for drug purchase, as it eliminates the purchase of misbranded drug purchased from non-reliable sources. Moreover, for inpatients, purchasing drugs from hospital pharmacy is easily accessible over retail stores.
“North America dominated the antiproliferative agents market in 2021”
North America dominated the antiproliferative agents market in 2021, due to the increasing healthcare expenditure, and the presence of well-established healthcare infrastructure which is fueling the growth of the overall regional market. For instance, according to the United States Food Drug Administration (USFDA) report 2021, there were 4,944 FDA-registered facilities for biologics developments and 6,799 for human drugs. Thus the increase in healthcare expenditure coupled with the presence of a well-established healthcare infrastructure would augment the growth of the market in this region.
Antiproliferative agents Market Report Coverage
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
- The report presents a quick review of overall industry performance at one glance.
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
- The study comprehensively covers the market across different segments.
- Deep dive regional level analysis of the industry.
Customization Options:
The global antiproliferative agents market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
Table of Contents
Research Methodology for the Antiproliferative Agents Market Analysis (2022-2028)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global antiproliferative agents market were the three major steps undertaken to create and analyze the adoption of antiproliferative agents in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global antiproliferative agents market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the antiproliferative agents market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the antiproliferative agents market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as drug type, dosage form, indication, route of administration, and end-users. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the antiproliferative agents market. Further, we conducted factor analysis using dependent and independent variables such as drug type, dosage form, indication, route of administration and end-users of the antiproliferative agents market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the antiproliferative agents market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global antiproliferative agents market, and market shares of the segments. All the required percentage shares split and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2028 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
- The industry’s market size, in terms of revenue (USD) and the adoption rate of the antiproliferative agents market across the major markets domestically
- All percentage shares, splits, and breakdowns of market segments and sub-segments
- Key players in the global antiproliferative agents market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global antiproliferative agents market. data was split into several segments & sub-segments post studying various parameters and trends in the areas of the drug type, dosage form, indication, route of administration and end-users in the global antiproliferative agents market.
The main Objective of the global antiproliferative agents Market Study
The current & future market trends of the global antiproliferative agents market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
- Analyze the current and forecast market size of the antiproliferative agents market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
- Segments in the study include areas of the drug type, dosage form, route of administration, indication and end-users Define and analysis of the regulatory framework for the antiproliferative agent’s industry
- Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
- Analyze the current and forecast market size of the antiproliferative agents market for the major region
- Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World
- Company profiles of the antiproliferative agents market and the growth strategies adopted by the market players to sustain in the fast-growing market
- Deep dive regional level analysis of the industry
Related Reports
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
